Article: P44 Incidence trends of hematological malignancies in belgium over 2004–2015: impact of the residence on chronic myeloid disorders

€3.03

SKU: product-article-14938 Category: General

Description
Reviews (0)

Description

P44 Incidence trends of hematological malignancies in belgium over 2004–2015: impact of the residence on chronic myeloid disorders

Reviews

There are no reviews yet.

Be the first to review “Article: P44 Incidence trends of hematological malignancies in belgium over 2004–2015: impact of the residence on chronic myeloid disorders”

You must be logged in to post a review.

Top

Article: P44 Incidence trends of hematological malignancies in belgium over 2004–2015: impact of the residence on chronic myeloid disorders

Description

Reviews

Related products

Article: Highlights in respiratory oncology

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: INTRODUCTION

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma